Yilong Wang

1.4k total citations · 1 hit paper
35 papers, 914 citations indexed

About

Yilong Wang is a scholar working on Molecular Biology, Oncology and Mechanical Engineering. According to data from OpenAlex, Yilong Wang has authored 35 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Mechanical Engineering. Recurrent topics in Yilong Wang's work include Additive Manufacturing Materials and Processes (8 papers), Additive Manufacturing and 3D Printing Technologies (6 papers) and Cancer-related gene regulation (4 papers). Yilong Wang is often cited by papers focused on Additive Manufacturing Materials and Processes (8 papers), Additive Manufacturing and 3D Printing Technologies (6 papers) and Cancer-related gene regulation (4 papers). Yilong Wang collaborates with scholars based in China, United States and Taiwan. Yilong Wang's co-authors include S. Diane Hayward, Kai Huang, Jon Finan, Jaap M. Middeldorp, Shu Yan, Fei Deng, Jiangui He, Pengchao Wang, Haihong Zhu and Changpeng Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Diabetes.

In The Last Decade

Yilong Wang

32 papers receiving 900 citations

Hit Papers

PRMT4 promotes ferroptosis to aggravate doxorubicin-induc... 2022 2026 2023 2024 2022 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yilong Wang China 16 412 244 170 168 126 35 914
Hui Shen China 16 361 0.9× 62 0.3× 84 0.5× 88 0.5× 138 1.1× 32 690
Ziyi Wang China 18 464 1.1× 143 0.6× 140 0.8× 92 0.5× 162 1.3× 83 1.1k
Lejia Sun China 17 229 0.6× 392 1.6× 96 0.6× 123 0.7× 160 1.3× 45 915
Xiaoqun Li China 22 979 2.4× 252 1.0× 350 2.1× 62 0.4× 104 0.8× 64 1.6k
Rutulkumar Patel United States 11 520 1.3× 148 0.6× 279 1.6× 157 0.9× 40 0.3× 21 1.1k
Dongyong Yang China 19 327 0.8× 111 0.5× 222 1.3× 182 1.1× 173 1.4× 61 941
Kihwan Kwon South Korea 15 311 0.8× 39 0.2× 124 0.7× 101 0.6× 111 0.9× 28 807
Yinghao Cao China 18 428 1.0× 309 1.3× 129 0.8× 140 0.8× 92 0.7× 80 1.2k
Feng Jin China 18 296 0.7× 152 0.6× 54 0.3× 137 0.8× 205 1.6× 58 1.0k
Atul Ranjan India 14 386 0.9× 195 0.8× 158 0.9× 82 0.5× 38 0.3× 29 760

Countries citing papers authored by Yilong Wang

Since Specialization
Citations

This map shows the geographic impact of Yilong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yilong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yilong Wang more than expected).

Fields of papers citing papers by Yilong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yilong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yilong Wang. The network helps show where Yilong Wang may publish in the future.

Co-authorship network of co-authors of Yilong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yilong Wang. A scholar is included among the top collaborators of Yilong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yilong Wang. Yilong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yilong, Minglu Liang, Kaiyuan Liu, et al.. (2025). BAP1 Suppresses White Adipose Tissue Browning and Thermogenesis Through Deubiquitinating KDM1B. Diabetes. 74(7). 1153–1167.
2.
Zhou, Lizhi, Yilong Wang, Shu Yan, et al.. (2024). PRMT4 interacts with NCOA4 to inhibit ferritinophagy in cisplatin‐induced acute kidney injury. The FASEB Journal. 38(7). e23584–e23584. 8 indexed citations
5.
Wang, Yilong, et al.. (2024). Residual deformation analysis of laser powder bed fusion-fabricated lattice structures. Virtual and Physical Prototyping. 19(1). 6 indexed citations
6.
Xu, Yuqin, et al.. (2024). R-loop and diseases: the cell cycle matters. Molecular Cancer. 23(1). 84–84. 16 indexed citations
7.
Wang, Yilong, Xiaoping Zheng, Lizhi Zhou, et al.. (2024). CHIP drives proteasomal degradation of NUR77 to alleviate oxidative stress and intrinsic apoptosis in cisplatin-induced nephropathy. Communications Biology. 7(1). 1403–1403.
8.
Zhong, Yi, Yilong Wang, Xiaoguang Li, et al.. (2023). PRMT4 Facilitates White Adipose Tissue Browning and Thermogenesis by Methylating PPARγ. Diabetes. 72(8). 1095–1111. 15 indexed citations
9.
Yan, Chenghui, Yilong Wang, Can Chen, et al.. (2022). GCN5-mediated regulation of pathological cardiac hypertrophy via activation of the TAK1-JNK/p38 signaling pathway. Cell Death and Disease. 13(4). 421–421. 26 indexed citations
10.
Yuan, Lin, Meng Du, Yilong Wang, et al.. (2022). RNF207 exacerbates pathological cardiac hypertrophy via post-translational modification of TAB1. Cardiovascular Research. 119(1). 183–194. 19 indexed citations
11.
Wang, Tingting, Yilong Wang, Changpeng Chen, & Haihong Zhu. (2021). Relationships between the characteristics of porosity, melt pool and process parameters in laser powder bed fusion Al Zn alloy. Journal of Manufacturing Processes. 68. 1236–1244. 21 indexed citations
12.
Hu, Ji, et al.. (2021). Dauricine Attenuates Vascular Endothelial Inflammation Through Inhibiting NF-κB Pathway. Frontiers in Pharmacology. 12. 758962–758962. 13 indexed citations
13.
Zhang, Yaqing, Yongjun Wang, Ruijun Ji, et al.. (2020). In-hospital complications affect short-term and long-term mortality in ICH: a prospective cohort study. Stroke and Vascular Neurology. 6(2). 201–206. 5 indexed citations
14.
Li, Jia, Jiangtong Peng, Shengnan Zhao, et al.. (2019). Tussilagone Suppresses Angiogenesis by Inhibiting the VEGFR2 Signaling Pathway. Frontiers in Pharmacology. 10. 764–764. 12 indexed citations
15.
Liu, Chang, Shu Yan, Yilong Wang, et al.. (2019). Poly(ADP-ribose) Polymerase-1 is required for hepatocyte proliferation and liver regeneration in mice. Biochemical and Biophysical Research Communications. 511(3). 531–535. 9 indexed citations
16.
Wang, Yilong, et al.. (2019). PRMT4 overexpression aggravates cardiac remodeling following myocardial infarction by promoting cardiomyocyte apoptosis. Biochemical and Biophysical Research Communications. 520(3). 645–650. 25 indexed citations
17.
Zhao, Shengnan, Minglu Liang, Yilong Wang, et al.. (2018). Chrysin Suppresses Vascular Endothelial Inflammation via Inhibiting the NF-κB Signaling Pathway. Journal of Cardiovascular Pharmacology and Therapeutics. 24(3). 278–287. 23 indexed citations
18.
Wang, Yilong, Hui Chen, Yi‐Qun Zhan, et al.. (2016). EWSR1 regulates mitosis by dynamically influencing microtubule acetylation. Cell Cycle. 15(16). 2202–2215. 17 indexed citations
19.
Xin, Baozhong, Junpeng Yan, Ying Wu, et al.. (2015). SAMHD1Gene Mutations Are Associated with Cerebral Large-Artery Atherosclerosis. BioMed Research International. 2015. 1–8. 5 indexed citations
20.
Wang, Yilong, Jon Finan, Jaap M. Middeldorp, & S. Diane Hayward. (1997). P32/TAP, a Cellular Protein That Interacts with EBNA-1 of Epstein–Barr Virus. Virology. 236(1). 18–29. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026